Purpose of the development: The drug is designed to inhibit pathogens of viral infections such as influenza, herpes, hepatitis, meningoencephalitis.

Recommended application field: Medicine.

Advantages over analogues: Consolidation into a single formulation of antibacterial and antiviral properties - a fundamentally new approach to the treatment of many diseases of mixed etiology.

The development stage readiness: Introduced in production

Technical and economic effect: Patents of Ukraine and Russia. Regulatory and technical documentation: Specifications for finished dosage form.

Description of the development:
()
Highly effective biological product is based on living aerobic spore-forming bacteria, which have high antiviral, antibacterial and immunomoduliruschuyu activity. The drug is effective with respect to the agents of viral infections such as influenza, herpes meningoencephalitis. Bacteria belonging to the subalin show high antagonistic activity to a wide range of pathogenic and opportunistic microorganisms.

Information about newness of the development:
there are Ukrainian patents -- 1 items
there are patents of other countries -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua